SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-133526
Filing Date
2022-04-29
Accepted
2022-04-29 16:02:20
Documents
5
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d244531ddef14a.htm DEF 14A 516027
2 GRAPHIC g244531d1.jpg GRAPHIC 3176
3 GRAPHIC g244531g00a00.jpg GRAPHIC 33323
4 GRAPHIC g244531g00a01.jpg GRAPHIC 27406
5 GRAPHIC g244531nb53.jpg GRAPHIC 6608
  Complete submission text file 0001193125-22-133526.txt   606502
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37465 | Film No.: 22875076
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences